Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation-Reference-Cited by-同舟云学术

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation

Published:2016-07 Issue: Volume:601 Page:113-120
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Messer Andrew E.,Bayliss Christopher R.,El-Mezgueldi Mohammed,Redwood Charles S.,Ward Douglas G.,Leung Man-Ching,Papadaki Maria,dos Remedios Cristobal,Marston Steven B.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference41 articles.

1. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity

2. How Do Mutations in Contractile Proteins Cause the Primary Familial Cardiomyopathies?

3. Dilated cardiomyopathy: the complexity of a diverse genetic architecture

4. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca2+ sensitivity

5. Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca2+-sensitivity in the pathogenesis of cardiomyopathy

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoids: Potential therapeutic agents for cardiovascular disease;Heliyon;2024-06

2. Nutraceuticals Silybin B, resveratrol and epigallocatechin-3 gallate (EGCG) bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutationsin vitro, in vivo, andin silico;2024-05-14

3. Exploring contractile protein mechanisms and target medications for cardiomyopathic patients with diastolic dysfunction;Pediatric Discovery;2024-03

4. Modulation of Structure and Dynamics of Cardiac Troponin by Phosphorylation and Mutations Revealed by Molecular Dynamics Simulations;The Journal of Physical Chemistry B;2023-10-04

5. Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment;Frontiers in Bioengineering and Biotechnology;2023-09-08